corneal reconstruction using tissue engineered epithelial
play

Corneal Reconstruction Using Tissue- Engineered Epithelial Cell Sheets Fabricated ex vivo From Autologous Oral Mucosal Epithelium Kohji Nishida, M.D., Ph.D. Department of Ophthalmology Sendai Tohoku University Graduate School of Medicine

0 downloads 3 Views 3,6 MB Size Report
  1. Corneal Reconstruction Using Tissue- Engineered Epithelial Cell Sheets Fabricated ex vivo From Autologous Oral Mucosal Epithelium Kohji Nishida, M.D., Ph.D. Department of Ophthalmology Sendai Tohoku University Graduate School of Medicine Tokyo Osaka

  2. Concept of Regenerative Medicine Concept of Regenerative Medicine (Tissue Engineering) (Tissue Engineering) Growth Factor Stem Cells Scafold from Vacanti & Langer Science 1993

  3. Tissue Stem Cells Tissue Stem Cells Epidermal stem cell Hair follicel stem cells eye brain liver heart muscle spleen Gastrointestinal Neural stem cells Hematopooetic stem cells stem cells pancreas bone kidney E . F u c h s , C e l l , 2 0 0 0 3

  4. Pluripotent Stem Cells Pluripotent Stem Cells Embryonic stem cells induced pluripotent stem cells

  5. Corneal Diseases Corneal Diseases Corneal epithelial Alkali, thermal disease epithelium burn Stvens-Johnson syndrome Stromal disease stroma Corneal dystrophy Endothelial Bullous disease endothelium keratopathy Standard therapy: allogeneic corneal transplanation using eye bank cornea

  6. Corneal Epithelial Stem Cell Corneal Epithelial Stem Cell cornea conjunctiva limbus cornea limbus Basal cells of Limbal epithelium conjunctiv =stem cells a

  7. Corneal epithelial stem cells Corneal epithelial stem cells Limbal stem cell Normal cornea deficiency epi cornea Thermal stroma limbus alkali injury endo Conj. SJS Stem cell Limbal stem cell deficiency Limbal stem cell deficiency Secondary Congenital Conjunctivalization Chemical burn Aniridia Thermal burn Primary Stevens-Johnson Idiopathic Ocular cicatricial ( Nishida K. Cornea 2003 ) 7 pemphigoid

  8. Long-Term Results of Corneal Transplantation for Corneal Epithelial Diseases Graft Survival(% ) 100 Chem Burn 80 SJS 60 Other (Solomon et al, 40 Ophthalmology, 2002) 20 0 High Risk of Rejection 0 20 40 60 80 100 120 Months SJS SJS OCP 8

  9. Organ/ tissue Regenerative Transplant Medicine Autologous Corneal transplant epithelial cell sheet transplantation Rejection Limited number of Donor cornea

  10. 10 Initial Report Initial Report Cultured corneal epithelial Cell source: Corneal epithelial sheet harvested by dispase stem cell treatment Pellegrini et al. Lancet 1997

  11. 11 The problems of Previous Methods The problems of Previous Methods Cell sheet harvest by dispase enzymatic proteolysis confluent cells marked degradation of cell-to-cell junction and ECM ⇒ fragile cell sheet Cell source: corneal epithelial stem cells Applied only to unilateral disease

  12. Cell sheet harvest Issue Cell sheet harvest Issue Use of Temperature responsive culture dish Use of Temperature responsive culture dish Cell Sheet Harvest Cell Sheet Harvest enzymatic enzymatic • 37 ℃ hydrophobic proteolysis proteolysis confluent cells confluent cells ⇒ cell attachment • below 32 ℃ hydrophilic reducing reducing ⇒ cell detachment temperature temperature � Retain cell-cell junctions as well as deposited � Retain cell-cell junctions as well as deposited extracellular matrix below the lower cell membranes extracellular matrix below the lower cell membranes Electron beam Electron beam Temperature-responsive Temperature-responsive monomer polymer

  13. 13 Cell attachment and detachment Cell attachment and detachment by temperature change by temperature change

  14. NEW TECHNOLOGY: tissue-engineered epithelial cell sheet tranplantation Limbal epithelium ディ スパーゼ処理 2mmX2mm MMC-3T3 feeder Temperature-responsive 37º C culture culture dish 2 weeks Tissue-engineered epithelial cell sheet 20º C harvest (Nishida K, Transplantation 2004)

  15. Cell sheet harvest Cultivated corneal sheet Cultivated oral mucosal sheet

  16. Characteristics of cultivated human corneal epithelial sheet H&E apical K3 basal Normal cornea (Nishida K, Transplantation 2004)

  17. 17 Bilateral diseases Autologous cell soruce Autologous cell soruce Unilateral diseases

  18. Transplantation of tissue- -engineered epithelial engineered epithelial Transplantation of tissue cell sheet for corneal diseases cell sheet for corneal diseases ( Nishida K et al. Transplantaion, 2004 ) ( Nishida K, et al. N Engl J Med 2004 )

  19. Histology Normal cornea Corneal epithelial cell sheet ( Nishida K et al. Transplantaion, 2004 ) Oral mucosal epithelial cell sheet Normal oral mucosa ( Nishida K, et al. N Engl J Med 2004 )

  20. Immunostaining for MUC 16 Corneal epithelium (in vivo) Oral mucosal epithelium (in vivo) Corneal epithelial cell sheet Oral mucosal cell sheet (Hori Y, et al Exp Eye Res 2008)

  21. Clinical Application Subjects Severe total limbal stem cell deficiency: Stevens-Johnson syndrome, Ocular cicatricial pemphigoid, Chemical burn, Thermal burn, Aniridia, etc Surgery Cell sheet transplantation using autologous cell soruce Post-operative management Topical administration of 0.3 % levofuloxacin and 0.1 % betamethasone four times daily Systemic administration of betamethasone (1-2 mg/day) for the first two weeks after surgery

  22. CASE Autologous Oral Epithelial Cell Sheet Transplantation to Treat Ocular Pemphigoid Pre-op 14 months post-op VA= 20/ 2000 VA= 20/ 25

  23. Results of I nitial 4 Cases Results of I nitial 4 Cases ( Nishida K, et al. N Engl J Med 2004 )

  24. CASE Autologous Oral Epithelial Cell Sheet Transplantation with PKP (epithelium scraped off) to Treat Stevens-Johnson syndrome (post PKP) Pre-op 3 year post-op VA= HM VA= 20/ 20

  25. CASE Autologous Epithelial Cell Sheet Transplantation with LKP (epithelium scraped off) and AMT to Treat Severe Thermal burn Pre-op 2 year post-op VA= HM VA= 20/ 200

  26. Surgical Results Best-Corrected Visual Acuity 20/20 Post-op visual acuity 20/200 20/2000 CF HD LP 20/2000 HD 20/200 CF 20/20 Pre-op visual acuity 27

  27. 28 Issues to be solved Issues to be solved Corneal Neovascularization Oral mucosal epithelial cell sheet induce peripheral neovascularization in some cases No neovascularization p r e o p e 3 y e a r s p o s t - o p e Neovascularization 2 y e a r s p o s t - o p e

  28. Quantification of Angiogenesis-Related Factors in Conditioned Medium from corneal sheet and oral sheet by ELISA (N=4 *; P<0.05 , Mann-Whitney test) • FGF2 was significantly higher in oral sheet than in corneal sheet., indicating that FGF2 is a candidate involved in the induction of corneal neovascularization after oral sheet transplantation. • Anti-FGF2 therapy may control the neovascularization after oral sheet transplantation.

  29. 30 Development of cultured corneal endothelial cell sheet transplantation 2. Fabrication and harvest of cultured 1.culture corneal endothelial cell sheet Epithelium HE 染色 Stroma Cell density endothelium > 3000/ mm 2 3. Transplantation surgery Corneal thickness Transplantation control (I de T, Nishida K, et al Biomaterials 2005) (Sumide T, Nishida K, et al FASEB J 2006)

  30. Corneal epithelial cells iPS cells Corneal production diseases iPS 細胞 上皮前駆細 胞 Corneal endothelial cells culture Autologous cells 遺伝子導入 遺伝子導入 ( Nanog, Sox2, Nanog, Sox2, 角膜内皮細胞 Klf4 等) 等) Klf4 角膜上皮シート 難治性角膜疾患 培養細胞シートの作 製 角膜上皮 培養細胞シート 移植 Autologous 角膜内皮 translat ion 角膜内皮シート

  31. 32 Conclusions 1. Clinical application of cell sheet transplantation using autologous limbal or oral mucosal epithelial stem cells are effective for reconstructing the corneal surface. 2. Corneal neovasucularization induced in peripheral cornea after oral mucosal cell sheet grafting should be controlled.

  32. 33 Acknowledgement Acknowledgement I nstitute of Advanced Department of Ophthalmology, Biomedical Engineering and Tohoku University Science, Tokyo Women’s Kubota A, Hayashi R, Takayanagi Medical University T, Yokokura R, Kanakubo A, Kikuchi M Yamato M, Kikuchi A, Yang J, Ryu T Okano T Department of Ophthalmology, Osaka University Medical School Soma T, Hayashida Y, Watanabe K, I de T, Sumide T, Saito T, Kaneyama S, Maeda N, Watanabe H, Hori Y, Tano Y Tokyo Osaka

Recommend Documents


epithelial tissue practice quiz 20 slides
Epithelial Tissue Practice Quiz (20

Epithelial Tissue Practice Quiz (20 slides) 1. Indicate the proper name of the

case report
Case Report: Managing corneal

Case Report: Managing corneal Interface Epithelial Ingrowth after SMILE Irene

epithelial tissue 46 thyroid gland h e details 1 stroma
EPITHELIAL TISSUE 46. Thyroid gland

Common details: blood vessels, nerve trunks, ganglions, adipose tissue,

history rces
History- RCES Recognized disease

12/3/2011 History- RCES Recognized disease entity >100 years Recurrent

simple squamous epithelial simple cuboidal epithelial
Simple Squamous Epithelial Simple

Simple Squamous Epithelial Simple Cuboidal Epithelial Simple Columnar

role of general practitioners in eye donation what is
ROLE OF GENERAL PRACTITIONERS IN EYE

ROLE OF GENERAL PRACTITIONERS IN EYE DONATION WHAT IS CORNEAL BLINDNESS?

breaking speed limits with simultaneous ultra fast mri
Breaking Speed Limits with Simultaneous

Breaking Speed Limits with Simultaneous Ultra-Fast MRI Reconstruction and

the effects of scaffold rigidity on retinal pigment
The Effects of Scaffold Rigidity on

The Effects of Scaffold Rigidity on Retinal Pigment Epithelial Cells Corina

corneal topography and
Corneal Topography and The Presenter

Disclosures: Corneal Topography and The Presenter and Organizers for Ortho-K

3d reconstruction reconstruction method
3D RECONSTRUCTION Reconstruction

3D RECONSTRUCTION Reconstruction method Reconstruction from images

where we are today
Where We Are Today April 8, 2020 New

Where We Are Today April 8, 2020 New and Cumulative COVID-19 Cases and

pulsed light hair removal
PULSED LIGHT HAIR REMOVAL A fast,

Palomar PULSED LIGHT HAIR REMOVAL A fast, comfortable and permanent

infinity
INFINITY AT HOME E DUCATION SE MIN AR

INFINITY AT HOME E DUCATION SE MIN AR HAIR REMOVAL HOW IT ALL BEGAN. + =

where we are today
Where We Are Today April 3, 2020 New

Where We Are Today April 3, 2020 New and Cumulative COVID-19 Cases and

alopecia areata
Alopecia areata Lidia Rudnicka

Alopecia areata Lidia Rudnicka Department of Dermatology, Medical University

the basis of evidence transfer and persistence
The Basis of Evidence: Transfer and

The Basis of Evidence: Transfer and Persistence Developed by Edmund Locard, a

full scale exercises
Full Scale Exercises An overview for

Full Scale Exercises An overview for the Safeguard Iowa Partnership Using

council of new jersey grantmakers improving grantmaking
Council of New Jersey Grantmakers:

Council of New Jersey Grantmakers: Improving Grantmaking with Data The

mimics of neoplasia in the gi tract slide seminar
Mimics of Neoplasia in the GI Tract

Mimics of Neoplasia in the GI Tract Slide Seminar Ismail Matalka Ayat

i mmune t herapy i n c lear
I mmune T herapy i n C lear C ell

I mmune T herapy i n C lear C ell Ovarian Cancer (ITICC) Hal Hirte Canadian

welcome
Welcome PURPOSE OF TODAYS HEARING To

Take me out to the ! ! ! g g g n n n i i i r r r a a a e e

pulpdent corporation pulpdent corporation
PULPDENT Corporation PULPDENT

PULPDENT Corporation PULPDENT Corporation Calcium Hydroxide Pastes Calcium